Stat5 phosphorylation is responsible for the excessive potency of HB‐EGF

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Cellular Biochemistry

• Publication date

  2018-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/jcb.26639PMID 29274275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Different Epidermal Growth Factor Receptor (EGFR) Agonists Produce Unique Signatures for the Recruitment of Downstream Signaling Proteins* ♦

  2016cited by this paper
• Effects of different ligands on epidermal growth factor receptor (EGFR) nuclear translocation.

  2016cited by this paper
• Internalization Mechanisms of the Epidermal Growth Factor Receptor after Activation with Different Ligands

  2013cited by this paper
• EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling

  2012cited by this paper
• HB‐EGF synthesis and release induced by cholesterol depletion of human epidermal keratinocytes is controlled by extracellular atp and involves both p38 and ERK1/2 signaling pathways

  2011cited by this paper
• The EGFR Ligands Amphiregulin and Heparin-Binding EGF-like Growth Factor Promote Peritoneal Carcinomatosis in CXCR4-Expressing Gastric Cancer

  2011cited by this paper
• Understanding resistance to EGFR inhibitors—impact on future treatment strategies

  2010cited by this paper
• Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo.

  2010cited by this paper
• EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR‐targeting tyrosine kinase inhibitors

  2010cited by this paper
• Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy

  2010cited by this paper
• Differential Effects of EGFR Ligands on Endocytic Sorting of the Receptor

  2009cited by this paper
• Jak2/Stat5 Signaling in Mammogenesis, Breast Cancer Initiation and Progression

  2008cited by this paper
• The complexity of targeting EGFR signalling in cancer: from expression to turnover.

  2006cited by this paper
• Protein transduction: cell penetrating peptides and their therapeutic applications.

  2006cited by this paper
• The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy

  2006cited by this paper
• EGF–ERBB signalling: towards the systems level

  2006cited by this paper
• Hematopoietic malignancies associated with increased Stat5 and Bcl-x(L) expressions in Ink4a/Arf-deficient mice.

  2005cited by this paper
• EGF receptor ligands.

  2003cited by this paper
• Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia.

  2002cited by this paper
• Signalling: STATs: transcriptional control and biological impact

  2002cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• STATs and gene regulation.

  1997cited by this paper
• Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway

  1995cited by this paper
• Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors

  1995cited by this paper
• Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin.

  1994cited by this paper
• Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate

  1993cited by this paper
• A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF

  1991cited by this paper

• Investigations on the Wound Healing Potential of Tilapia Piscidin (TP)2-5 and TP2-6

  2022cites this paper
• T cell derived HB-EGF prevents Th17 cell differentiation in an autocrine way

  2021cites this paper
• Geniposide alleviates choroidal neovascularization by downregulating HB-EGF release from RPE cells by downregulating the miR-145-5p/NF-κB axis.

  2021cites this paper
• Collagen/glycosaminoglycan-based matrices for controlling skin cell responses

  2021cites this paper
• Heparin-binding epidermal growth factor inhibits apoptosis in cisplatin-resistant pancreatic cancer cells via upregulation of EGFR and ERCC 1 expressions

  2021cites this paper
• HB-EGF Activates the EGFR/HIF-1α Pathway to Induce Proliferation of Arsenic-Transformed Cells and Tumor Growth

  2020cites this paper
• Hyaluronan/collagen hydrogels containing sulfated hyaluronan improve wound healing by sustained release of heparin-binding EGF-like growth factor.

  2019cites this paper